150 related articles for article (PubMed ID: 21320355)
1. Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].
Jensen AD; Nikoghosyan A; Hinke A; Debus J; Münter MW
BMC Cancer; 2011 Feb; 11():70. PubMed ID: 21320355
[TBL] [Abstract][Full Text] [Related]
2. The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
Adeberg S; Akbaba S; Lang K; Held T; Verma V; Nikoghosyan A; Bernhardt D; Münter M; Freier K; Plinkert P; Hauswald H; Herfarth K; Rieken S; Debus J; Jensen AD
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):167-173. PubMed ID: 31586664
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HIT.
Jensen AD; Krauss J; Potthoff K; Desta A; Habl G; Mavtratzas A; Windemuth-Kiesselbach C; Debus J; Münter MW
BMC Cancer; 2011 May; 11():182. PubMed ID: 21595970
[TBL] [Abstract][Full Text] [Related]
4. RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab.
Jensen AD; Krauss J; Weichert W; Debus J; Münter MW
Radiat Oncol; 2010 Nov; 5():102. PubMed ID: 21047402
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC.
Jensen AD; Nikoghosyan A; Windemuth-Kieselbach C; Debus J; Münter MW
BMC Cancer; 2010 Oct; 10():546. PubMed ID: 20937120
[TBL] [Abstract][Full Text] [Related]
6. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
[TBL] [Abstract][Full Text] [Related]
7. Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol.
Habl G; Jensen AD; Potthoff K; Uhl M; Hof H; Hajda J; Simon C; Debus J; Krempien R; Münter MW
BMC Cancer; 2010 Nov; 10():651. PubMed ID: 21108850
[TBL] [Abstract][Full Text] [Related]
8. Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study.
Lang K; Adeberg S; Harrabi S; Held T; Kieser M; Debus J; Herfarth K
BMC Cancer; 2021 Jul; 21(1):812. PubMed ID: 34266402
[TBL] [Abstract][Full Text] [Related]
9. Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518).
Jensen AD; Münter MW; Bischoff H; Haselmann R; Timke C; Krempien R; Sterzing F; Nill S; Heeger S; Hoess A; Haberkorn U; Huber PE; Steins M; Thomas M; Debus J; Herfarth KK
BMC Cancer; 2006 May; 6():122. PubMed ID: 16681848
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck.
Jensen AD; Debus J
Radiat Oncol; 2019 Nov; 14(1):194. PubMed ID: 31694720
[TBL] [Abstract][Full Text] [Related]
11. IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer.
Zwicker F; Roeder F; Thieke C; Timke C; Münter MW; Huber PE; Debus J
Strahlenther Onkol; 2011 Jan; 187(1):32-8. PubMed ID: 21234529
[TBL] [Abstract][Full Text] [Related]
12. COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
Jensen AD; Nikoghosyan AV; Lossner K; Haberer T; Jäkel O; Münter MW; Debus J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):37-46. PubMed ID: 26279022
[TBL] [Abstract][Full Text] [Related]
13. Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12).
Jensen AD; Nikoghosyan AV; Windemuth-Kieselbach C; Debus J; Münter MW
BMC Cancer; 2011 May; 11():190. PubMed ID: 21600049
[TBL] [Abstract][Full Text] [Related]
14. Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Chaudhri N; Uhl M; Münter MW; Herfarth KK; Debus J
Radiother Oncol; 2015 Feb; 114(2):182-8. PubMed ID: 25640299
[TBL] [Abstract][Full Text] [Related]
15. Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series.
Bernhardt D; Sterzing F; Adeberg S; Herfarth K; Katayama S; Foerster R; Hoerner-Rieber J; König L; Debus J; Rieken S
Cancer Manag Res; 2018; 10():583-588. PubMed ID: 29618938
[TBL] [Abstract][Full Text] [Related]
16. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.
Akbaba S; Ahmed D; Lang K; Held T; Mattke M; Hoerner-Rieber J; Herfarth K; Rieken S; Plinkert P; Debus J; Adeberg S
Oral Oncol; 2019 Apr; 91():39-46. PubMed ID: 30926061
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas.
Schulz-Ertner D; Nikoghosyan A; Jäkel O; Haberer T; Kraft G; Scholz M; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):391-8. PubMed ID: 12738314
[TBL] [Abstract][Full Text] [Related]
18. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.
Montejo ME; Shrieve DC; Bentz BG; Hunt JP; Buchman LO; Agarwal N; Hitchcock YJ
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e845-52. PubMed ID: 21167654
[TBL] [Abstract][Full Text] [Related]
19. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Welzel T; Uhl M; Federspil PA; Freier K; Krauss J; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Radiother Oncol; 2016 Feb; 118(2):272-80. PubMed ID: 26164774
[TBL] [Abstract][Full Text] [Related]
20. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment.
Münter MW; Schulz-Ertner D; Hof H; Nikoghosyan A; Jensen A; Nill S; Huber P; Debus J
Radiat Oncol; 2006 Jun; 1():17. PubMed ID: 16756669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
